Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 20.20 INR
Change Today 0.00 / 0.00%
Volume 0.0
As of 6:10 AM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

sandu pharmaceuticals (SNDP) Snapshot

Open
20.00
Previous Close
20.65
Day High
20.90
Day Low
20.00
52 Week High
03/13/15 - 24.80
52 Week Low
05/13/14 - 8.37
Market Cap
143.0M
Average Volume 10 Days
5.1K
EPS TTM
1.10
Shares Outstanding
7.1M
EX-Date
--
P/E TM
18.4x
Dividend
--
Dividend Yield
--
Current Stock Chart for SANDU PHARMACEUTICALS (SNDP)

Related News

No related news articles were found.

sandu pharmaceuticals (SNDP) Related Businessweek News

No Related Businessweek News Found

sandu pharmaceuticals (SNDP) Details

Sandu Pharmaceuticals Limited manufactures and markets ayurvedic medicines primarily in India and internationally. The company offers medicines in the areas of cardiovascular systems, endocrine systems, digestive systems, genito-urinary systems, muscular skeletal systems, nervous systems, male reproductive systems, respiratory systems, and nutrition. It also provides medicines for gynaecological; skin; and ear, nose, and throat disorders. The company was founded in 1899 and is based in Mumbai, India.

Founded in 1899

sandu pharmaceuticals (SNDP) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

sandu pharmaceuticals (SNDP) Key Developments

Sandu Pharmaceuticals Ltd. Appoints Nikesh Shah as Chief Financial Officer

Sandu Pharmaceuticals Ltd. has informed that Shri Nikesh Shah has been appointed as the Chief Financial Officer of the company with effect from March 02, 2015 in accordance with the provisions of Section 203 of the Companies Act, 2013 read with Rule 8 of the Companies (Appointment & Remuneration of Managerial Personnel) Rules, 2014, at the meeting of the Board of Directors held on February 14, 2015.

Sandu Pharmaceuticals Limited, Board Meeting, Feb 14, 2015

Sandu Pharmaceuticals Limited, Board Meeting, Feb 14, 2015. Agenda: To consider quarterly results.

Sandu Pharmaceuticals Limited Reports Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2014

Sandu Pharmaceuticals Limited reported unaudited standalone earnings results for the second quarter and six months ended September 30, 2014. For the quarter, the company reported net sales/income from operations (net of excise duty) of INR 109.168 million compared to INR 104.657 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 5.702 million compared to INR 3.682 million a year ago. Profit from ordinary activities before tax was INR 2.156 million compared to profit from ordinary activities before tax of INR 1.541 million a year ago. Net profit was INR 1.481 million against net profit of INR 1.010 million a year ago. Basic and diluted earnings per share before extraordinary items were INR 0.21 against INR 0.14 last year. For the six months, the company reported net sales/income from operations (net of excise duty) of INR 201.618 million compared to INR 189.298 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 9.863 million compared to INR 6.974 million a year ago. Profit from ordinary activities before tax was INR 3.199 million compared to profit from ordinary activities before tax of INR 2.964 million a year ago. Net profit was INR 2.582 million against net profit of INR 2.137 million a year ago. Basic and diluted earnings per share before extraordinary items were INR 0.36 against INR 0.30 last year.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SNDP:IN 20.20 INR 0.00

SNDP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SNDP.
View Industry Companies
 

Industry Analysis

SNDP

Industry Average

Valuation SNDP Industry Range
Price/Earnings 22.7x
Price/Sales 0.4x
Price/Book 0.8x
Price/Cash Flow 11.4x
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SANDU PHARMACEUTICALS, please visit www.sandu.in. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.